Safety of Autologous Umbilical Cord Blood Therapy for Acquired Sensorineural Hearing Loss in Children
2018
This article presents the results of a phase 1 clinical trial to evaluate the intravenous administration of human umbilical cord blood (hUCB) mononuclear fraction in infants and children with acquired sensorineural hearing loss (SNHL).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
27
References
9
Citations
NaN
KQI